Serum adiponectin levels are reduced in autism spectrum disorder and association with severity of symptoms.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 491, doi. 10.1007/s11011-020-00668-2
- By:
- Publication type:
- Article
Works matching IS 08857490 AND DT 2021 AND VI 36 AND IP 3
Results: 14
1
2
Lipid metabolic dysregulation is involved in Parkinson's disease dementia.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 463, doi. 10.1007/s11011-020-00665-5
- By:
- Publication type:
- Article
3
Biochemical, histological, and neuro-physiological effects of long-term aluminum chloride exposure in rats.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 429, doi. 10.1007/s11011-020-00664-6
- By:
- Publication type:
- Article
4
MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 421, doi. 10.1007/s11011-020-00663-7
- By:
- Publication type:
- Article
5
Polygala sabulosa A.W. Bennett extract mitigates motor and cognitive deficits in a mouse model of acute ischemia.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 453, doi. 10.1007/s11011-020-00660-w
- By:
- Publication type:
- Article
6
Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 437, doi. 10.1007/s11011-020-00658-4
- By:
- Publication type:
- Article
7
Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 509, doi. 10.1007/s11011-020-00656-6
- By:
- Publication type:
- Article
8
Identification of MMACHC and PROKR2 mutations causing coexistent cobalamin C disease and Kallmann syndrome in a young woman.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 447, doi. 10.1007/s11011-020-00654-8
- By:
- Publication type:
- Article
9
The pathophysiological mechanism of ischemic stroke after hypobaric hypoxia simulation at high altitude.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 483, doi. 10.1007/s11011-020-00653-9
- By:
- Publication type:
- Article
10
Thrombin generation and activity in multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
11
Carnosic acid depends on glutathione to promote mitochondrial protection in methylglyoxal-exposed SH-SY5Y cells.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 471, doi. 10.1007/s11011-020-00651-x
- By:
- Publication type:
- Article
12
A computational approach to analyse the amino acid variants of GLB1 protein causing GM1 Gangliosidosis.
- Published in:
- Metabolic Brain Disease, 2021, v. 36, n. 3, p. 499, doi. 10.1007/s11011-020-00650-y
- By:
- Publication type:
- Article
13
Mercury and Alzheimer's disease: a look at the links and evidence.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
14
A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review